Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima

This study aimed to exercise the Sanger sequencing strategy for screening of variants among confirmed COVID-19 cases and validate our strategy against NGS strains in Hiroshima retrieved from GISAID. A total of 660 samples from confirmed COVID-19 cases underwent screening for variants by Sanger-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Ko, Takahashi, Kazuaki, Nagashima, Shintaro, E, Bunthen, Ouoba, Serge, Takafuta, Toshiro, Fujii, Yoshiki, Mimori, Michi, Okada, Fumie, Kishita, Eisaku, Ariyoshi, Kunie, Hussain, Md Razeen Ashraf, Sugiyama, Aya, Akita, Tomoyuki, Kuwabara, Masao, Tanaka, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030034/
https://www.ncbi.nlm.nih.gov/pubmed/35458450
http://dx.doi.org/10.3390/v14040720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030034/
https://www.ncbi.nlm.nih.gov/pubmed/35458450
http://dx.doi.org/10.3390/v14040720

Ejemplares similares